Clorox: Stable Revenue And Strong Dividend Program, But Too Expensive
Clorox is considered recession-proof due to its essential products and strong brand, but its shares are too expensive, given its profitability. CLX has underperformed the market significantly, facing competition and changing consumer preferences, which limits its growth and profitability. Despite stable revenue, CLX's high operating costs and declining margins make it less attractive compared to tech giants with better growth prospects.
Clorox's Strategic Vision Entails Balancing Growth Amid Cost Woes
CLX navigates cost challenges while driving growth through strategic investments, innovation and global expansion.
Zacks Industry Outlook The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox
The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox have been highlighted in this Industry Outlook article.
BofA reveals stocks with a history of steady returns amid market volatility
Trump tariffs have already hurt US stocks significantly in recent weeks but the Fed's latest warning of stickier inflation and an economic slowdown ahead signals the worst may not be over just yet.
Clorox Stock Trades Below 200 & 50-Day SMA: How to Play the Stock?
CLX navigates cost challenges while driving growth through strategic investments, innovation and global expansion.
Why Is Clorox (CLX) Up 1.7% Since Last Earnings Report?
Clorox (CLX) reported earnings 30 days ago. What's next for the stock?
Clorox's IGNITE Plan & Other Strategic Efforts Progress Well
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
The Clorox Company (CLX) Consumer Analyst Group of New York Conference (CAGNY) 2025 (Transcript)
The Clorox Company (NYSE:CLX ) Consumer Analyst Group of New York Conference (CAGNY) 2025 February 20, 2025 2:00 PM ET Company Participants Linda Rendle - Chair and Chief Executive Officer Kevin Jacobsen - Executive Vice President and Chief Financial Officer Luc Bellet - Treasurer and incoming Chief Financial Officer Conference Call Participants Unidentified Company Representative Good afternoon. Next up, it is my pleasure to welcome Clorox back to the CAGNY stage.
Clorox Stock Falls 7.2% Post Q2 Earnings: Time to Buy or Hold?
CLX faces near-term pressure from weak earnings and ongoing operational transitions, but its long-term strategy bodes well.
3 Reasons Why This Ultra-Safe High-Yield Dividend Stock Is Worth Buying Now
Shares of Clorox (CLX -0.43%) are down 7.4% since it reported earnings on Feb. 3. The consumer goods company continues to make big changes it hopes can chart a path toward margin expansion.
Wells Fargo Upgraded These 3 Stocks—Here's Why They Stand Out
Now that the first quarter of 2025 is underway, investors across the board are probably looking to find the best ideas to get their portfolios started on the right foot. This way, they can have not only the momentum but also the liquidity necessary to chase the growth plays that will become available in later months.
Clorox Analysts Boost Their Forecasts Following Upbeat Earnings
Clorox Company CLX reported better-than-expected second-quarter financial results Monday after the bell.
